HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
48.78 USD
+0.29 (+0.6%)
50.32 USD
+1.54 (+3.16%)
Taking everything into account, HIMS scores 6 out of 10 in our fundamental rating. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS shows excellent growth, but is valued quite expensive already. These ratings could make HIMS a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of HIMS (10.31%) is better than 95.05% of its industry peers.
HIMS has a Return On Equity of 34.41%. This is amongst the best in the industry. HIMS outperforms 95.05% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.74%, HIMS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (9.62%) than 92.08% of its industry peers.
Looking at the Operating Margin, with a value of 6.80%, HIMS is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
HIMS's Gross Margin of 76.20% is amongst the best of the industry. HIMS outperforms 89.11% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 6.92. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.92, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
HIMS has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as HIMS would need 8.11 years to pay back of all of its debts.
HIMS has a Debt to FCF ratio (8.11) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.72 is on the high side and indicates that HIMS has dependencies on debt financing.
With a Debt to Equity ratio value of 1.72, HIMS is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 6.92 |
ROIC/WACC0.73
WACC9.18%
2.3 Liquidity
A Current Ratio of 4.98 indicates that HIMS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.98, HIMS belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
A Quick Ratio of 4.46 indicates that HIMS has no problem at all paying its short term obligations.
HIMS's Quick ratio of 4.46 is amongst the best of the industry. HIMS outperforms 92.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 88.69%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 21.25% on average per year.
EPS Next Y11.74%
EPS Next 2Y22.49%
EPS Next 3Y23.28%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.1%
Revenue Next 3Y31.07%
Revenue Next 5Y21.25%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 60.98, which means the current valuation is very expensive for HIMS.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 60.21 indicates a quite expensive valuation of HIMS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, HIMS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.98 | ||
| Fwd PE | 60.21 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 60.40% of the companies in the same industry.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 92.26 | ||
| EV/EBITDA | 65.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 23.28% in the coming years.
PEG (NY)5.2
PEG (5Y)1.01
EPS Next 2Y22.49%
EPS Next 3Y23.28%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
48.78
+0.29 (+0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change-0.09%
Ins Owners10.28%
Ins Owner Change-2.46%
Market Cap11.03B
Revenue(TTM)2.01B
Net Income(TTM)193.60M
Analysts68
Price Target49.8 (2.09%)
Short Float %32.95%
Short Ratio2.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)-3.07%
PT rev (3m)1.17%
EPS NQ rev (1m)-2.06%
EPS NQ rev (3m)-35.34%
EPS NY rev (1m)-2.22%
EPS NY rev (3m)-11.45%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.98 | ||
| Fwd PE | 60.21 | ||
| P/S | 5.48 | ||
| P/FCF | 92.26 | ||
| P/OCF | 42.14 | ||
| P/B | 19.59 | ||
| P/tB | 27.27 | ||
| EV/EBITDA | 65.22 |
EPS(TTM)0.8
EY1.64%
EPS(NY)0.81
Fwd EY1.66%
FCF(TTM)0.53
FCFY1.08%
OCF(TTM)1.16
OCFY2.37%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)5.2
PEG (5Y)1.01
Graham Number6.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 6.92 |
F-Score6
WACC9.18%
ROIC/WACC0.73
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y11.74%
EPS Next 2Y22.49%
EPS Next 3Y23.28%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.73%
Revenue Next 2Y38.1%
Revenue Next 3Y31.07%
Revenue Next 5Y21.25%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y60%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 6 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.74% in the next year.